Qualium Investissement, a private equity investment firm, completed the acquisition of Proengin, a manufacturer of chemical and biological warfare agent detection systems, from Capital Export. Financial terms were not disclosed. “Leveraging its unique technology and best-in-class industrial know-how, Proengin has significant potential to create value, unleashed by the new management team led by Jean-François Brun since 2018. We are pleased to partner with Proengin in the development of new applications and the opening up of new markets through its strong international deployment model,” Jacques Pancrazi, Qualium Investissement Partner.